Article Details
Retrieved on: 2021-07-10 10:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Eventual expansions to treat additional complement-mediated disorders like Alexion's drugs could make this stock a big winner for patient investors. In ...
Article found on: www.fool.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here